Entering text into the input field will update the search result below

Rigel Pharmaceuticals, Inc.'s (RIGL) CEO Raul Rodriguez on Q1 2022 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET

Company Participants

Dolly Vance - EVP, Corporate Affairs and General Counsel

Raul Rodriguez - President and Chief Executive Officer

Wolfgang Dummer - EVP and Chief Medical Officer

Dave Santos - EVP and Chief Commercial Officer

Dean Schorno - EVP and Chief Financial Officer

Caroline Piatek - Associate Professor of Clinical Medicine

Conference Call Participants

Eun Yang - Jefferies

Gary Nachman - BMO Capital Markets

Kalpit Patel - B. Riley Securities

Joseph Pantginis - H.C. Wainwright & Co.

Robert Hazlett - BTIG


Greetings, welcome to Rigel Pharmaceuticals Financial Conference Call for the First Quarter 2022. At this time, all participants are in listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce our first speaker, Dolly Vance, who is Rigel’s Executive Vice President, Corporate Affairs and General Counsel. Thank you. Ms. Vance, you may now begin.

Dolly Vance

Thank you. Welcome to our first quarter 2022 financial results and business update conference call. The financial press release for the first quarter was issued a short while ago and can be viewed along with the accompanying slides for this presentation in the News & Events section of our Investor Relations site on www.rigel.com.

As a reminder, during today’s call, we may make forward-looking statements regarding our financial outlook and our plans and timing for regulatory and product development. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. A description of these risks can be found in our most recent Annual Report on Form 10-K for the year ended December 31, 2021 and subsequent filings with the SEC, including our December 31 quarterly report on Form

Recommended For You

Comments (2)

Not selling a single share, good news are coming soon…
@seeking alibaba When is that good news coming? lol
To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About RIGL

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on RIGL

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.